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Introduction 
Giant Cell Arteritis (GCA) is a major area of clinical risk, due to a combination of the 
seriousness of the condition, challenges in its diagnosis and the associated morbidity of its 
treatment.  Admissions for investigation of suspected GCA currently shows an upward 
trend [1]; hence a reliable, noninvasive test is required. Temporal artery biopsy (TAB) is 
specific, but surgically invasive.  Using ultrasound to identify temporal artery oedema (“the 
halo sign”), stenosis and occlusion has gained popularity.  A meta-anaylsis reported the 
sensitivity and specificity for unilateral halo sign as 68% and 91%, respectively.[2] 
Ultrasound is cheaper, non-invasive, permits longitudinal scanning for disease activity and 
can be quicker to organise than TAB, but requires experience.[2,3] Magnetic resonance 
imaging and angiography [4]  has also been used to image the superficial temporal artery 
but access and high expense has limited its widespread use. 
 
Optical Coherence Tomography (OCT) is a noninvasive interferometric optical imaging 
modality [5].  Dermal OCT devices are capable of imaging tissues in vivo, including distinct 
skin layers up to 2mm in depth, and the acquisition time is short. [6] Dermal OCT uses 
longer infrared wavelengths (1300nm) compared to that conventionally used in ophthalmic 
OCT (800 nm). Both dermatological and ophthalmic OCT   machines have demonstrated 
the ability to image arterial microvascular structures [7,8].  To the authors’ knowledge OCT 
has not yet been used in GCA or health to image the superficial temporal artery (STA). 
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Materials and methods 
We used a commercially available dermatological multi-beam, Fourier-domain, swept 
source OCT device (InVivoSight; Michelson Diagnostics, Kent, UK) with a wavelength of 
1305nm (HSL- 2000; Santec Corp, Komaki, Japan), an axial optical resolution of 10μm 
and lateral optical resolution of 7.5μm.  The aim was to test the hypothesis that the STA 
could be imaged using dermal OCT.  We scanned eight individuals, all over the age of 50 
years: five had a clinical diagnosis of GCA (TAB positive n=3; TAB negative n=2) and 
three were healthy controls, with no prior history of GCA symptoms or ophthalmic history 
(other than cataracts). Three cases are presented here to illustrate the preliminary imaging 
findings.  Ethical approval was obtained and informed consent was taken.  
 
Results 
In this proof of concept case series eight individuals were scanned. In all eight (1) the STA 
could be localized by palpation to align the OCT tracer beam, (2) the STA  could be 
identified on OCT ‘free-run’ mode and (3) the STA could then be captured, in part, on 
‘multi-scan’ mode to obtain the desired 6.0 x 6.0mm grid of high-resolution stack of images 
with 0.1mm separation between slices and 2.0mm slice depth.   
 
A specific limitation of the technology was found with depth of penetration at around 2mm, 
therefore in some cases only the more proximal wall of the artery and lumen were 
captured.  A hyperreflective band that probably corresponds to elastin within the external 
elastic lamina and possibly including the internal elastic lamina, distinguished artery from 
vein. (figures1, 2A, 3).  Signal drop out is seen on the images as linear artifact from skin 
hairs.  Where the whole circumference of the artery was captured in the image, a ratio of 
band thickness (BT) to arterial lumen diameter (ALD) could be calculated (BT:ALD ratio) 
using the device software.    
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The following 3 cases were chosen to demonstrate the capability of the device: Case 1 
and 3 illustrate the ability to calculate the BT:ALD ratio and Case 2 shows the presence 
and absence of the hyperreflective band. 
Case 1 
A 69 year old caucasian female presented with bilateral artertic anterior ischemic optic 
neuropathies.  TAB was positive.  Figure 1 images are from the contralateral side to TAB 
site 9 months after diagnosis.  The white arrows demonstrate a hyperreflective band 
isolating the vessel lumen, corresponding to the thicker connective tissue wall of an artery 
rather than vein.  BT=22μm, ALD=240μm; BT:ALD ratio 0.092. 
Case 2 
A 68 old caucasian male diagnosed with unilateral artertic anterior ischemic optic 
neuropathy.  TAB was positive.  Images in figure 2 are taken 4 weeks post-diagnosis and 
ongoing corticosteroid treatment.  Figure 2A demonstrates the artery distal to TAB site; 
figure 2B observes a vessel without the hyperreflective band likely to be a vein. 
Case 3 
A 72 year old systemically well caucasian male, was reviewed for cataracts (control). The 
arrow demonstrates the hyperreflective band of the artery in figure 3.  BT=21μm, 
ALD=213μm; BT:ALD ratio 0.099. 
 
Discussion 
We have demonstrated that transdermal OCT can identify the STA. The preliminary 
images presented here need further validation.  We found specific limitations of the 
technology such as the depth of penetration; in some cases only the proximal vessel wall 
and lumen were captured.  Also artifact from overlying hairs masked image data that may 
in future investigations be problematic.  We did not attempt to scan the parietal branch of 
the STA and given its position beyond the hairline may not be possible due to hair follicle 
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artifact.  Current developments in the technology include enhanced depth imaging which 
may see image data increased by 50% greater depth.   No coupling agent was used and it 
is probable in future investigations that this may reduce artifact. 
 
Potentially transdermal OCT has a number of advantages over TAB as it is quick and 
noninvasive; and could be performed serially over time.  OCT allows image acquisition by 
a novice, permits detailed retrospective analysis of all images, with extremely high 
resolution enabling assessment and measurement of structural changes down to a few 
microns.  The axial resolution of OCT images achieved here is less than 20 μm, up to 10 
times higher than conventional ultrasound and magnetic resonance imaging. 
 
As a significant number of patients with large vessel GCA do not have demonstrable 
temporal artery abnormalities this could limit the development of dermal OCT for GCA as 
here we have only demonstrated imaging of the STA.  Additionally current expense of the 
platform may hinder widespread clinical access for cranial GCA. 
 
These cases provide a proof of concept that transdermal OCT can image parts of the STA.  
A large scale validation study of this imaging modality is required to provide evidence that 
this technique is meaningful in the diagnosis of GCA. 
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What was known before 
The diagnosis of GCA is an area of major challenge to rheumatologists, internal physicians 
and ophthalmologists. 
Imaging techniques for the STA that are currently being used both for diagnosis and 
monitoring in GCA include ultrasound and magnetic resonance imaging/magnetic 
resonance angiography.   
Histopathology from a temporal artery biopsy is still considered the definitive investigation 
for diagnosis of GCA. 
What this study adds 
This is the first report that the superficial temporal artery can be identified and imaged, in 
part, non-invasively using a commercially-available dermal OCT instrument. 
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Titles and legends to figures 
Figure Legend 
Figure 1A, 1B and 1C are dermal OCT images from case 1.  The white arrows highlights 
the hyper-reflective band seen.  Areas of loss of signal, relate to hair follicle artifact. (TAB 
positive) 
Figure 2 are dermal OCT images from Case 2.  2A demonstrates the STA distal to the 
TAB site; 2B observes a vessel without the hyperreflective band likely to be a vein. (TAB 
positive) 
Figure 3 is a dermal OCT image from case 3, where the hyper-reflective band is identified 
by the white arrow. (Control case) 
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